Immune System - Part II basis of the immunological response mediated by T and B lymphocytes

Revista Brasileira de Reumatologia

Volumn 50, Issue 5, 2010, Pages 566-580

  Mesquita Júnior, Danilo ^a   Araújo, Júlio Antônio Pereira ^a   Catelan, Tânia Tieko Takao ^a   de Souza, Alexandre Wagner Silva ^a   Cruvinel, Wilson de Melo ^a   Andrade, Luís Eduardo Coelho ^a   da Silva, Neusa Pereira ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; Inflammation; Innate immunity; PAMPs; Toll like receptors

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; T LYMPHOCYTE RECEPTOR;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; GENE SWITCHING; HUMAN; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

B-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 78649555188     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology, 6a ed, Editora Saunders 2007.
2. a ed, Editora Artmed, 2002.
3. Rudin CM, Thompson CB. B-Cell Development and Maturation. Seminar in Oncology 1998; 25(4):435-46.
4. Van Zelm M, Reisli I, Van der Burg M, Castaño D, Van Noesel CJM, Van Tol MJD et al. An antibody deficiency syndrome due to mutations in the CD19 gene. N. England J Med 2006; 354:1901-12.
5. László M, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nature Rev Immunology 2007; 7:851-61.
6. Van Lochem EG, Van der Velden VHJ, Wind HK, Te Marvelde JG, Westerdaal NAC, Van Dongen JJM. Immunophenotypic Differentiation Patterns of Normal Hematopoiesis in Human Bone Marrow: Reference Patterns for Age-Related Changes And Disease-Induced Shifts. Cytometry - Part B (Clinical Cytometry) 2004; 60B:1-13.
7. McHeyzer-Williams MG: B cells as effectors. Curr Opin Immunol 2003; 15(3):354-61.
8. Gray D, Gray M, Barr T. Innate responses of B cells. Eur J Immunol 2007; 37(12):3304-10.
9. Wen L, Roberts SJ, Viney JL, Wong FS, Mallick C, Findly RC. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature 1994; 369:654-8.
10. Peng SL, Madaio MP, Hughes DP, Crispe IN, Owen MJ, Wen L. Murine lupus in the absence of alpha beta T cells. J Immunol 1996; 156:4041-9.
11. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006; 176(2):705-10.
12. Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol 2008; 29(1):34-40.
13. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 1997; 186(10):1749-56.
14. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008; 20(2):149-57.
15. Hardy RR: B-1 B cell development. J Immunol 2006; 177(5):2749-54.
16. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev 2006; 5(6):403-8.
17. Stutman O. Intrathymic and extrathymic T cell maturation. Immunol Rev 1978; 42:138-84.
18. Parkin J, Cohen B. An overview of the immune system. Lancet 2001; 357: 1777-89.
19. Bradley LM. Migration and T-lymphocyte effector function. Curr Opin Immunol 2003; 15(3):343-8.
20. Tuerlinckx D, Vermylen C, Brichard B, Ninane J, Cornu G. Disseminated Mycobacterium avium infection in a child with decreased tumour necrosis factor production. Eur J Pediatr 1997; 156(3):204-6.
21. Mesquita Jr. D, Cruvinel WM, Câmara NOS, Kállas EG, Andrade LEC. Autoimmune diseases in the TH17 era. Braz J Med Biol Res 2009; 42(6):476-486.
22. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Distinct Regulation of Interleukin-17 in Human T Helper Lymphocytes. Arthritis & Rheumatism 2007; 56(9):2936-46.
23. Modlin RL, Sieling PA. Now Presenting: T γδ Cells. Science 2005; 309:252-3.
24. Holtmeier W, Kabelitz D. Gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy 2005; 86:151-83.
25. Cruvinel WM, Mesquita Jr. D, Araujo JAP, Salmazi KC, Kállas EG, Andrade LEC. Natural Regulatory T cells in Rheumatic Diseases. Rev Bras Reumatol 2008; 48(6):342-355.
26. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155(3):1151-64.
27. Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004; 114(9):1198-208.
28. Lu L, Werneck MBF, Cantor H. The immunoregulatory effects of Qa-1 Immunological Reviews 2006; 212:51-9.
29. Sttrober S, Dejbachsh-Jones S, Van Vlasselaer P, Duwe G, Salimi S, Allison JP. Cloned natural supressor cell lines express CD3+ CD4-CD8-surface phenotype and the alpha, beta heterodimer of the T cell antigen receptor. J Immunol 1989; 143:1118-22.
30. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002; 196(10):1335-46.
31. Murison JG, Quaratino S, Londei M. Phenotypic and functional heterogeneity of double negative (CD4-CD8-) alpha beta TcR+ T cell clones. Curr Top Microbiol Immunol 1991; 173:215-20.
32. Wang R, Wang-Zhu Y, Grey H. Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci USA 2002; 99:2181-6.
33. Ben-David H, Sharabi A, Dayan M, Sela M, Mozes E. The role of CD8+CD28-regulatory cells in suppressing myasthenia gravis - associated responses by dual altered peptide ligand PNAS 2007; 104(44):17459-64.
34. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nature Rev. Immunol 2007; 7:505-18.
35. MacDonald HR. Development and function of natural killer 1+ T-cells. Biochem Soc Trans 1997; 25(2):696-9.
36. Yokoyama WM. Betting on NKT and NK cells. Immunity 2004; 20(4):363-5.
37. Granucci F, Zanoni I, Ricciardi-Castagnoli P. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell Mol Life Sci 2008; 65:1683-97.
38. Cruz PD Jr, Bergstresser PR. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness. Dermatol Clin 1990; 8(4):633-47.
39. Shortman K, Wu L, Süss G, Kronin V, Winkel K, Saunders D et al. Dendritic cells and T lymphocytes: developmental and functional interactions. Ciba Found Symp 1997; 204:130-8.
40. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.